华纳药厂：获得卡前列素氨丁三醇注射液药品注册证书

Core Viewpoint - Warner Pharmaceuticals has received approval from the National Medical Products Administration for the registration certificate of Carboprost Tromethamine Injection, indicating a significant advancement in its product portfolio [1] Company Summary - The Carboprost Tromethamine Injection is primarily indicated for the treatment of abortion during the 13 to 20 weeks of pregnancy and for postpartum hemorrhage caused by uterine atony when conventional methods are ineffective [1] - The product has been classified as a Category 4 chemical drug under the new registration classification, which is equivalent to passing the consistency evaluation [1]